31
51
Growth Score
-9 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
752223
CD Biopharma develops and commercializes innovative tumor immunotherapy drugs.
About the Company
CD Biopharma develops and commercializes innovative tumor immunotherapy drugs. It focuses on the core pipeline of PD-1AB21 (PD-1 antibody and IL-21 fusion protein), with tumor-specific T Precision combination therapies such as cell therapy, CART cell therapy, and tumor vaccines are the flanks. Adhering to the concept and purpose of
"truth-seeking, innovation, precision, focus, and cooperation", the company's innovative development is achieved through the close combination of solid basic science and translational medicine.
